Heine Høi Hansen

Title: Heine Høi Hansen: Innovator in Cancer Research

Introduction

Heine Høi Hansen is a notable inventor based in Holte, Denmark. He has made significant contributions to the field of cancer research, particularly in the area of tumor growth inhibition. His innovative approaches aim to improve therapeutic methods for treating malignancies.

Latest Patents

Heine Høi Hansen holds 1 patent related to his work. The patent, titled "Suppression of inhibitors," focuses on methods for inhibiting malignant tumor growth, invasion, and metastasis in patients. The invention outlines a method that involves suppressing the inhibitory activity of a protease or a non-proteolytic matrix-degrading enzyme (IPNME) in malignant tumor tissue. This suppression can be achieved by administering compounds that interact with the IPNME or by influencing the transcription of genes encoding the IPNME. The patent also discusses methods for selecting and identifying compounds for therapeutic use in treating malignancies.

Career Highlights

Heine Høi Hansen is associated with Cancerforskningsfonden Af 1989, an organization dedicated to cancer research. His work has been instrumental in advancing the understanding of tumor biology and developing new treatment strategies.

Collaborations

Heine has collaborated with notable colleagues in his field, including Vincent Ellis and John Rømer. These partnerships have contributed to the advancement of cancer research and the development of innovative therapeutic methods.

Conclusion

Heine Høi Hansen's contributions to cancer research through his patent and collaborative efforts highlight his commitment to improving treatment options for malignancies. His innovative methods represent a significant step forward in the fight against cancer.